関連する実験動画
Updated: Sep 9, 2025

10:36
Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
19.8K
プロバイオティクス:婦人科疾患に対する有用性,効果,リスク
Madeline Carmain1, Elisabeth C Sappenfield, Elena Tunitsky-Bitton
1Department of Urogynecology, Hartford Hospital, Hartford, Connecticut, USA.
Current opinion in obstetrics & gynecology
|September 2, 2025
まとめ
プロバイオティクスは,バクテリア性陰道炎 (BV),再発性尿路感染症 (UTI),ヒトパピローマウイルス (HPV) の治療に有望である. 最適な結果のために特定の株を決定するには,さらなる研究が必要です.
科学分野:
- 微生物学
- 婦人科
- 泌尿器科
背景:
- 感染を防ぐには の微生物群が不可欠です
- プロバイオティクスは 陰道の健康を回復する可能性を調査しています
- 抗生物質の低リスクの代替品として 益生菌への関心が高まっています
研究 の 目的:
- ヴァルボ感染の管理におけるプロバイオティクスの有効性を検討する.
- 陰道微生物群の正常化における プロバイオティクスの役割を評価する.
- 細菌性陰道炎 (BV),尿路感染症 (UTI),ヒトパピローマウイルス (HPV) の治療法としてプロバイオティクスを調査する.
主な方法:
- 陰道と尿路の健康のためのプロバイオティクスの介入に関する最近の研究のレビュー
- バクテリア性陰道炎,vulvovaginal candidiasis,UTI,HPVに対するプロバイオティクスの効果を調査した研究の分析
- Dマノースやクランベリーなどの他の治療法と併用したプロバイオティクスの評価
主要な成果:
- プロバイオティクスは,抗生物質と併用すると,再発性バクテリア性陰道炎 (BV) の予防に役立ちます.
- プロバイオティクスは,vulvovaginal candidiasisの再発を防ぐのに有効ではありません.
- プロバイオティクスは,非抗生物質のバンドルの一部として,再発性尿路感染症 (76%) を著しく減少させます.
- プロバイオティクスは,HPVをクリアし,異常なパパニコラウ検査結果を解消する可能性を示しています.
結論:
- プロバイオティクスは,BV,再発性尿路感染症およびHPVの治療に有効であることが示されています.
- 特定のプロバイオティクスの菌株や製品は,対象となる用件に関してさらなる調査が必要である.
- プロバイオティクスは様々な婦人科や泌尿器科の 治療に適した治療法です
関連する概念動画
Drugs for Treatment of Constipation-Predominant IBS
326
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
326
Microorganisms in Medicine and Therapeutics
312
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
312
Bacterial Flora of the Large Intestine
641
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
641
Drugs for Treatment of Diarrhea-Predominant IBS
292
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
292
Irritable Bowel Syndrome III: Medical and Nursing Management
294
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
294
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
413
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
413

